Table 5.
Impact of age on the parameters at the end of therapy
| Parameters | Age > 39 yr(n=11) | Age < 39 yr(n=8) | P value |
| AST (U/L) | 32.91 | 30.25 | 0.82 |
| ALT (U/L) | 30.09 | 32.25 | 0.81 |
| HCV-RNA (log10 IU/mL) | 2.92 | 2.33 | 0.7 |
| WBC (109/L) | 4.28 | 6.04 | 0.53 |
| Hemoglobin (G/L) | 109.18 | 88.75 | 0.11 |
| Creatinine (Umol/L) | 148.73 | 124.63 | 0.46 |
| GFR (mL/min) | 67.73 | 68.88 | 0.92 |
AST: Aspartate aminotransferase; ALT: Abnormal alanine aminotransferase; HCV: Hepatitis C virus; WBC: White cell count; GFR: Glomerular filtration rate.